Atlas Trials

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Clinical trial NCT00998036 · COMPLETED

Trial details

NCT number
NCT00998036
Sponsor
Columbia University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2009-09-01
Primary completion
2012-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.